Literature DB >> 1536234

Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic.

J C Robinson1, S Plichta, C S Weisman, C A Nathanson, M Ensminger.   

Abstract

OBJECTIVES: This study examined the prevalance of dysmenorrhea in female adolescents and the effect of experiencing a reduction in dysmenorrhea on oral contraceptive use. STUDY
DESIGN: This was a prospective panel study in which 308 adolescent women at an inner-city family planning clinic were interviewed about their experiences with dysmenorrhea and their oral contraceptive use at three points in time over a 6-month period. A chi 2 test and multiple logistic regression analysis were done.
RESULTS: The overall prevalence of dysmenorrhea in this population was 79.6%; 18.2% reported severe dysmenorrhea. Those who had severe dysmenorrhea and also experienced the reduction of dysmenorrhea as a result of oral contraceptives were eight times more likely to be consistent oral contraceptive users (p less than or equal to 0.02).
CONCLUSIONS: It is important to screen female adolescents for dysmenorrhea, provide them with information about the beneficial side effects of oral contraceptives, and follow up these young women to make sure they are experiencing the alleviation of their symptoms.

Entities:  

Keywords:  Adolescents; Adolescents, Female; Age Factors; Americas; Contraception; Contraceptive Methods; Contraceptive Usage; Data Analysis; Data Collection; Demographic Factors; Developed Countries; Diseases; Dysmenorrhea; Family Planning; Maryland; Measurement; Menstruation Disorders; North America; Northern America; Oral Contraceptives; Population; Population Characteristics; Prevalence; Prospective Studies; Research Methodology; Statistical Regression; Studies; United States; Urban Population; Youth

Mesh:

Substances:

Year:  1992        PMID: 1536234     DOI: 10.1016/0002-9378(92)91676-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

Review 1.  Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks.

Authors:  Jan Brynhildsen
Journal:  Ther Adv Drug Saf       Date:  2014-10

Review 2.  Noncontraceptive health benefits of oral contraceptives.

Authors:  Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 3.  Behavioural interventions for primary and secondary dysmenorrhoea.

Authors:  M L Proctor; P A Murphy; H M Pattison; J Suckling; C M Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 4.  Dysmenorrhoea.

Authors:  Michelle L Proctor; Cynthia M Farquhar
Journal:  BMJ Clin Evid       Date:  2007-03-01

5.  Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women.

Authors:  Nayoung Kim; Ha-Na Yoo; Hye Sun Hyun; Dong-Yun Lee; Byung-Koo Yoon; Doo-Seok Choi
Journal:  Obstet Gynecol Sci       Date:  2015-09-22

6.  Vitamin K acupuncture pint injection for severe primary dysmenorrhea: an international pilot study.

Authors:  Li Wang; Francesco Cardini; Wenjie Zhao; Anna Laura Regalia; Christine Wade; Emanuela Forcella; Jin Yu
Journal:  MedGenMed       Date:  2004-12-27

Review 7.  A contemporary approach to dysmenorrhea in adolescents.

Authors:  Zeev Harel
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Hormonal contraception in adolescents: special considerations.

Authors:  Rollyn M Ornstein; Martin M Fisher
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

9.  Multimodal Therapy Combining Spinal Manipulation, Transcutaneous Electrical Nerve Stimulation, and Heat for Primary Dysmenorrhea: A Prospective Case Study.

Authors:  Jessica J Wong; Michelle Laframboise; Silvano Mior
Journal:  J Chiropr Med       Date:  2018-08-28

10.  A randomised placebo-controlled trial of a traditional Chinese herbal formula in the treatment of primary dysmenorrhoea.

Authors:  Lan Lan Liang Yeh; Jah-Yao Liu; Kao-Si Lin; Yu-Shen Liu; Jeng-Min Chiou; Kung-Yee Liang; Te-Feng Tsai; Li-Hsiang Wang; Chiung-Tong Chen; Ching-Yi Huang
Journal:  PLoS One       Date:  2007-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.